Active, not recruitingNCT05149755

Evolut™ EXPAND TAVR II Pivotal Trial

Medtronic CardiovascularMultiple US sitesView on ClinicalTrials.gov

AI Description

Obtain safety and effectiveness data to support indication expansion for the Medtronic TAVR System to include patients with moderate, AS.

Report inaccurate information

Who can join
older adult
Participants
650
Expected completion
2034-12
Funded by
industry

Conditions studied

Moderate Aortic Valve Stenosis

What is being tested

  • DEVICE: Medtronic Evolut PRO+ TAVR System, or Evolut FX TAVR System, and guideline-directed management and therapy (GDMT)

What it measures

  • Composite rate of all-cause mortality, all-stroke, life threatening or fatal bleeding, acute kidney injury, hospitalization due to device or procedure-related complication, or valve dysfunction requiring reintervention., Life threatening or fatal bleeding is defined as BARC Type 3 or 4 and acute kidney injury is defined as VARC-3 Stage IV., 30 days
  • Composite rate of all-cause mortality, heart failure hospitalization or event, or medical instability leading to aortic valve replacement or re-intervention., 2 years

Centers Participating

These centers are participating in this study. Reach out to them directly to learn more.

NexVal Center

Tampa General Hospital

Tampa, FL

Abbott Northwestern Hospital

Minneapolis, MN

Ascension St. Vincent's Riverside

Jacksonville, FL

Aurora St. Luke's Medical Center

Milwaukee, WI

Baystate Medical Center

Springfield, MA

Beth Israel Deaconess Medical Center

Boston, MA

Carilion Roanoke Memorial Hospital

Roanoke, VA

Cleveland Clinic

Cleveland, OH

Corewell Health Butterworth Hospital

Grand Rapids, MI

Deborah Heart & Lung Center

Browns Mills, NJ

Englewood Hospital

Englewood, NJ

Erlanger Medical Center

Chattanooga, TN

Hartford Hospital

Hartford, CT

Henry Ford St. John Hospital (Detroit)

Detroit, MI

HonorHealth Scottsdale Shea Medical Center

Scottsdale, AZ

Houston Methodist Hospital

Houston, TX

J.W. Ruby Memorial Hospital

Morgantown, WV

Kettering Health Main Campus

Kettering, OH

Lauder Family Cardiovascular Center

New York, NY

Lehigh Valley Hospital–Cedar Crest

Allentown, PA

Los Robles Regional Medical Center

Thousand Oaks, CA

Mayo Clinic (Rochester, Minnesota)

Rochester, MN

Medical City Heart Hospital (Dallas)

Dallas, TX

MedStar Washington Hospital Center

Washington, DC

Methodist Hospital

San Antonio, TX

Michigan Medicine Cardiovascular Center

Ann Arbor, MI

Mission Hospital (Asheville)

Asheville, NC

Monument Health Rapid City Hospital

Rapid City, SD

Morton Plant Hospital (Clearwater)

Clearwater, FL

New England Heart and Vascular Institute

Manchester, NH

OHSU Hospital

Portland, OR

Orlando Health

Orlando, FL

Pinnacle Health Cardiovascular Institute

Harrisburg, PA

Providence Sacred Heart Medical Center & Children's Hospital

Spokane, WA

Sandra Atlas Bass Heart Hospital at North Shore University Hospital

Manhasset, NY

SSM Health Saint Louis University Hospital

Saint Louis, MO

St. Vincent's Medical Center

Bridgeport, CT

Tallahassee Memorial HealthCare

Tallahassee, FL

Terrebonne General Medical Center

Houma, LA

Texas Health Harris Methodist Hospital Fort Worth

Fort Worth, TX

The Johns Hopkins Hospital

Baltimore, MD

The Ohio State University Wexner Medical Center

Columbus, OH

The University of Vermont Medical Center

Burlington, VT

Tufts Medical Center

Boston, MA

UAB Hospital

Birmingham, AL

UF Health Shands Hospital

Gainesville, FL

University Hospitals Cleveland Medical Center

Cleveland, OH

University of Colorado Hospital

Aurora, CO

UofL Health – Jewish Hospital

Louisville, KY

Data Sources and Methodology

Registry entry updated 2026-05-19

Deciding whether to join a study is your choice, and you can ask a study team questions before you decide anything.